Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy

被引：0
|
作者：
Daofu Feng
Meiha Leong
Ting Li
Lin Chen
Tao Li
机构：
[1] General Hospital of Chinese PLA,Department of General Surgery
[2] General Hospital of Tianjin Medical University,Department of General Surgery
[3] Kiang Wu Hospital,Department of Surgery
来源：
World Journal of Surgical Oncology | / 13卷
关键词：
Gastric cancer; D2 lymphadenectomy; Pathological complete response; Complications; Neoadjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer
    Hirohiko Sato
    Mitsuo Shimada
    Nobuhiro Kurita
    Takashi Iwata
    Kozo Yoshikawa
    Jun Higashigima
    Motoya Chikakio
    Hideya Kashihara
    Chie Takasu
    Noriko Matsumoto
    Shozo Eto
    International Journal of Clinical Oncology, 2015, 20 : 543 - 548
  • [32] Neoadjuvant apatinib plus tegafur/gimeracil/oteracil potassium (S-1)/oxaliplatin chemotherapy vs. chemotherapy alone in patients with locally advanced gastric carcinoma
    Wang, Zhenfeng
    He, Tingbang
    Yu, Deguo
    Qin, Xiantao
    Geng, Aizhi
    Yang, Hailei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 24 (04)
  • [33] Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection
    Sun, Yongkun
    Yang, Lin
    Wang, Chengfeng
    Zhao, Dongbing
    Cai, Jianqiang
    Li, Wenbin
    Zhang, Wen
    Huang, Jing
    Zhou, Aiping
    ONCOTARGET, 2017, 8 (43) : 75186 - 75194
  • [34] Randomized, multicenter, controlled evaluation of S-1 and oxaliplatin (SOX regimen) as neoadjuvant chemotherapy for advanced gastric cancer patients (RESONANCE trial).
    Li, Tao
    Chen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [35] S-1 Combined with Oxaliplatin as Preoperative Chemotherapy followed by Surgery Shows Better Surgical Outcomes Compared with Surgery Alone for Advanced Gastric Cancer Patients
    Li, T.
    Chen, L.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S150 - S150
  • [36] A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced gastric cancer
    Ohnuma, H.
    Sato, Y.
    Takayama, T.
    Sagawa, T.
    Hirakawa, M.
    Harada, K.
    Nobuoka, T.
    Hirata, K.
    Sato, Y.
    Takahashi, Y.
    Katsuki, S.
    Takahashi, S.
    Hirayama, M.
    Takahashi, M.
    Maeda, M.
    Sato, T.
    Miyanishi, K.
    Kobune, M.
    Takimoto, R.
    Kato, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] S-1 with leucovorin and oxaliplatin for advanced gastric cancer
    ter Veer, Emil
    van Oijen, Martijn G. H.
    van Laarhoven, Hanneke W. M.
    LANCET ONCOLOGY, 2016, 17 (02): : E41 - E41
  • [38] Adjuvant chemotherapy for chemotherapy-naive advanced gastric cancer patients with oxaliplatin plus tegafur versus oxaliplatin plus S-1
    Shu, Zhenbo
    Ding, Dayong
    Li, Yongchao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (06): : 9322 - 9329
  • [39] Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601
    Iwatsuki, Masaaki
    Orita, Hiroyuki
    Kobayashi, Kazuma
    Hidaka, Shigekazu
    Arigami, Takaaki
    Kusumoto, Tetsuya
    Satake, Hironaga
    Oki, Eiji
    Tsutsumi, Satoshi
    Tobimatsu, Kazutoshi
    Shimokawa, Mototsugu
    Saeki, Hiroshi
    Makiyama, Akitaka
    Baba, Hideo
    Mori, Masaki
    GASTRIC CANCER, 2022, 25 (01) : 180 - 187
  • [40] Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601
    Masaaki Iwatsuki
    Hiroyuki Orita
    Kazuma Kobayashi
    Shigekazu Hidaka
    Takaaki Arigami
    Tetsuya Kusumoto
    Hironaga Satake
    Eiji Oki
    Satoshi Tsutsumi
    Kazutoshi Tobimatsu
    Mototsugu Shimokawa
    Hiroshi Saeki
    Akitaka Makiyama
    Hideo Baba
    Masaki Mori
    Gastric Cancer, 2022, 25 : 180 - 187
12345